AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glyciday M 40mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Beats Pharmaceuticals

Salt Composition

Gliclazide (40mg) + Metformin (500mg)

Overview Glyciday M 40mg/500mg Tablet

Diabexe Duo 40mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo 40mg/500mg should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a holistic diabetes management plan including diet, exercise, and weight management as recommended by your doctor. Lifestyle choices significantly influence diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Prompt glucose intake (sugary foods or juice) is essential to counter hypoglycemia. Alcohol consumption should be minimized due to increased hypoglycemia risk. Other possible side effects encompass altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (blood cell counts and liver function) are recommended.

Uses of Glyciday M 40mg/500mg Tablet

Adult-onset diabetes

Major Benefits of Glyciday M 40mg/500mg Tablet:

Consume Glyciday M 40mg/500mg tablets as directed by your physician, adhering precisely to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. This medication should be taken with food.

Common Side effects of Glyciday M 40mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glyciday M 40mg/500mg Tablet:

Administer Glyciday M 40mg/500mg tablets as prescribed by your physician, ingesting the entire tablet with food. Do not divide, crush, or chew the medication.

How Glyciday M 40mg/500mg Tablet works:

Gliclazide and Metformin, combined as Glyciday M 40mg/500mg tablets, offer dual-action diabetes management.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glyciday M 40mg/500mg tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Use of Glyciday M 40mg/500mg tablets is contraindicated during pregnancy due to confirmed risk to the fetus. Exceptionally, a physician might prescribe it in emergencies where potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Glyciday M 40mg/500mg tablets are likely not safe for use while breastfeeding. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.

DrivingDrivingCAUTION

Impaired driving is possible with abnormally high or low blood glucose levels. Refrain from driving if you experience such symptoms.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Glyciday M 40mg/500mg tablets, potentially requiring dose modification. Physician consultation is recommended. Glyciday M 40mg/500mg tablets are contraindicated in individuals with severe kidney disease. Close monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glyciday M 40mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. A reduced initial dose is typically advised for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.

What if you forget to take Glyciday M 40mg/500mg Tablet :

Should you forget a Glyciday M 40mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glyciday M 40mg/500mg Tablet

LabelValue
Addictive None.
Type of Medication Medication for diabetes

FAQs on Glyciday M 40mg/500mg Tablet

Glyciday M 40mg/500mg tablets contain gliclazide and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action therapy enhances glycemic control when combined with a healthy diet and regular physical activity. Gliclazide stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose production and improves insulin responsiveness. This formulation is unsuitable for managing type 1 diabetes.
Glyciday M 40mg/500mg tablets may cause common adverse reactions such as low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects, including lactic acidosis, are also possible. Prolonged administration might result in vitamin B12 deficiency.
Indeed, Glyciday M 40mg/500mg Tablets may induce hypoglycemia (low blood glucose). Manifestations of low blood sugar can encompass nausea, headache, irritability, hunger pangs, sweating, lightheadedness, tachycardia, and feelings of anxiety or tremor. The likelihood of hypoglycemia increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying readily available glucose tablets, honey, or fruit juice is advisable.
Glyciday M 40mg/500mg Tablets may cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an infrequent adverse reaction to metformin. To mitigate risk, its use is contraindicated in individuals with pre-existing kidney impairment, the elderly, and heavy alcohol consumers. Lactic acidosis symptoms can manifest as muscle aches or weakness, lightheadedness, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Glyciday M 40mg/500mg Tablet use and seek immediate medical attention.
Prolonged Glyciday M 40mg/500mg Tablet use can indeed lead to vitamin B12 deficiency. This is because the medication impairs the stomach's absorption of vitamin B12. Untreated deficiency may result in anemia, neurological issues such as tingling and numbness in the extremities, muscle weakness, urinary dysfunction, cognitive changes, and balance problems (ataxia). Preventive measures proposed by some researchers include annual supplemental vitamin B12 intake.
Patients with a history of hypersensitivity to any ingredient or inactive component in Glyciday M 40mg/500mg Tablets should not use this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Glyciday M 40mg/500mg tablets and alcohol is unsafe. Concurrent use may lead to dangerously low blood sugar (hypoglycemia) and heighten the risk of lactic acidosis.
Glyciday M 40mg/500mg tablets contain gliclazide and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action medication enhances glycemic control when coupled with a balanced diet and regular physical activity. Gliclazide's mechanism involves stimulating pancreatic insulin secretion, while metformin reduces hepatic glucose production and improves cellular insulin responsiveness. This formulation is unsuitable for managing type 1 diabetes.
Glyciday M 40mg/500mg tablets may cause common adverse reactions such as low blood sugar (hypoglycemia), altered taste perception, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially severe side effects, including lactic acidosis, are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Glyciday M 40mg/500mg Tablets may induce hypoglycemia (low blood sugar). Low blood sugar can manifest as nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. The risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying glucose tablets, honey, or fruit juice is recommended.
Glyciday M 40mg/500mg Tablets may cause lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this is an uncommon adverse reaction to metformin. Risk factors include pre-existing kidney impairment, advanced age, and high alcohol consumption. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms appear, discontinue Glyciday M 40mg/500mg Tablet use and seek immediate medical attention.
Glyciday M 40mg/500mg Tablet's prolonged administration may induce vitamin B12 deficiency. This is because the medication impedes the stomach's absorption of vitamin B12. Untreated deficiency can lead to anemia, neurological complications such as paresthesia in the extremities, general weakness, urinary dysfunction, cognitive impairment, and gait instability. Prophylactic annual supplementation with external vitamin B12 sources is recommended by some studies to mitigate these risks.
Patients exhibiting hypersensitivity to any ingredient or inactive component within Glyciday M 40mg/500mg Tablet should not use this medication. Its use is also contraindicated in individuals with moderate to severe renal impairment or pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Consuming alcohol while taking Glyciday M 40mg/500mg tablets is unsafe. This combination risks dangerously low blood sugar (hypoglycemia) and heightened lactic acidosis probability.
Glyciday M 40mg/500mg Tab...
45
MRP 55
18% off